Foto: Laura Gochicoa, presidente della Global Lung Initiative (GLI), e Sundeep Salvi, direttore globale della Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), hanno visitato lo stand di Sunvou.

At the American Thoracic Society (ATS) 2025 International Meeting, held in San Francisco, USA from May 16 to 21, 2025, Sunvou Medical showcased the world's first clinical combined breath test device, which garnered widespread attention from participants and professionals attending the event. Leading respiratory experts from North America, Europe, and other regions, after experiencing the technology firsthand and learning about its clinical applications, stated that the product “provides a completely new and complete solution for the clinical diagnosis of airway diseases.”

During the exhibition, the innovative device attracted considerable interest from clinicians, researchers, and industry representatives who were eager to explore its potential role in improving respiratory disease assessment and patient management. Academic leaders from international organizations such as GINA, GOLD, and GLI expressed their willingness to collaborate with Sunvou Medical to jointly develop standards for innovative technologies, promote the harmonization of clinical practices, standardize the clinical use of related tests, and maximize their clinical value in routine respiratory care.

Foto: Gregory Downey, ex presidente dell'American Thoracic Society (ATS), ha visitato lo stand Sunvou

Anche le soluzioni di Sunvou Medical per l'assistenza primaria e il monitoraggio della salute respiratoria a domicilio hanno ricevuto un'ampia attenzione, con diverse istituzioni mediche internazionali già in discussione per l'introduzione dei prodotti. Questa mostra ha ulteriormente consolidato la posizione di leader di Sunvou nella diagnosi e nel trattamento delle vie respiratorie a livello mondiale.